SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suraksha Diagnostic informs about disclosure

09 Dec 2024 Evaluate
Pursuant to Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended, and the Company’s Policy for Determination of Materiality of Events or Information, Suraksha Diagnostic has informed that the Board of Directors of the Company have authorized the Key Managerial Personnel (‘KMP’) of the Company to determine the materiality of an event or information and for the purpose of making the necessary disclosures to the stock exchanges under Regulation 30 of SEBI Listing Regulations, as details enclosed.

The above information is a part of company’s filings submitted to BSE.

Suraksha Diagnostic Share Price

282.05 0.60 (0.21%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×